# Egis Pharmaceuticals PLC · 66-66 · HUNGARY — FDA import alert red lists: firms subject to detention without physical examination

For Egis Pharmaceuticals PLC · 66-66 · HUNGARY, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is HUNGARY; product code is 61 U - - 05 Tamoxifen Citrate (Anti-Estrogen); date published is 09/30/2009; address is Kereszturi Ut 30-38 , Budapest, Budapest HUNGARY, verified against its source on 2026-09-16.

- **Firm:** Egis Pharmaceuticals PLC _(verified: appears in the quote below)_
- **Import alert:** 66-66
- **Import alert name:** "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- **Country:** HUNGARY _(verified: appears in the quote below)_
- **Address:** Kereszturi Ut 30-38 , Budapest, Budapest HUNGARY _(verified: appears in the quote below)_
- **Date published:** 09/30/2009 _(verified: appears in the quote below)_
- **Product code:** 61 U - - 05 Tamoxifen Citrate (Anti-Estrogen) _(verified: appears in the quote below)_
- **FDA notes:** 11/2/2000 _(verified: appears in the quote below)_

## What the source says

> Egis Pharmaceuticals PLC Date Published : 09/30/2009 Kereszturi Ut 30-38 , Budapest, Budapest HUNGARY 61 U - - 05 Tamoxifen Citrate (Anti-Estrogen) Date Published: 09/30/2009 Notes: 11/2/2000

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_202.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).